ATNM · Actinium Pharmaceuticals, Inc. · Documents
Market Cap
$38.67M
Shares
31.44M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-14 | 2026-08-12 | |
| 10-Q | 2026-08-07 | 2026-06-30 | |
| 8-K | 2026-06-18 | — | |
| 8-K | 2026-05-29 | 2026-05-27 | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K/A | 2026-03-26 | 2025-11-26 | |
| 8-K | 2026-02-13 | 2026-02-11 | |
| 8-K | 2025-11-26 | — | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| DEF 14A | 2025-11-05 | 2025-11-26 | |
| 10-Q | 2025-08-08 | 2025-06-30 | |
| 10-Q | 2025-05-09 | 2025-03-31 | |
| 8-K | 2025-05-09 | 2025-05-08 | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2024-11-27 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| DEF 14A | 2024-11-05 | 2024-11-27 | |
| 8-K | 2024-11-05 | 2024-11-01 | |
| 10-Q | 2024-08-05 | 2024-06-30 | |
| 8-K | 2024-08-05 | — | |
| 10-Q | 2024-04-26 | 2024-03-31 | |
| 10-K | 2024-03-29 | 2023-12-31 | |
| 8-K | 2023-12-01 | 2023-11-30 | |
| DEF 14A | 2023-11-09 | 2023-11-30 | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 10-Q | 2023-08-14 | 2023-06-30 | |
| 10-Q | 2023-05-15 | 2023-03-31 | |
| 10-K | 2023-03-31 | 2022-12-31 | |
| 8-K | 2023-03-10 | — | |
| 8-K | 2023-02-21 | 2023-02-18 | |
| 8-K | 2022-12-30 | — | |
| 8-K | 2022-12-09 | 2022-12-08 | |
| DEF 14A | 2022-11-21 | 2022-12-08 | |
| 10-Q | 2022-11-14 | 2022-09-30 | |
| 8-K | 2022-10-31 | — | |
| 10-Q | 2022-08-12 | 2022-06-30 | |
| 8-K | 2022-06-29 | 2022-06-28 | |
| 10-Q | 2022-05-13 | 2022-03-31 | |
| 8-K | 2022-04-13 | 2022-04-07 | |
| 10-K | 2022-03-25 | 2021-12-31 | |
| 10-Q | 2021-11-12 | 2021-09-30 | |
| 8-K | 2021-11-09 | — | |
| DEF 14A | 2021-10-18 | 2021-11-09 | |
| 8-K | 2021-09-23 | 2021-09-22 | |
| 10-Q | 2021-07-30 | 2021-06-30 | |
| 10-Q | 2021-05-14 | 2021-03-31 | |
| 10-K | 2021-03-31 | 2020-12-31 | |
| 8-K | 2020-11-20 | 2020-11-18 | |
| 8-K | 2020-10-28 | — |
Showing 1–50 of 69 filings
Key facts
CIK
1388320
CUSIP
00507W206
13F (30d)
30 filings
30 filers
Visit website
Investor relations